AstraZeneca’s Tezspire receives approval for asthma treatment
Green light for new asthma pen which offers self-administration option across the EU
Read More
Tag: tezspire
AstraZeneca’s Tezspire approved in the EU for patients with severe asthma
Tezspire is a maintenance therapy for patients with no phenotype or biomarker limitations
Read More
- Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
- Corcept Therapeutics’ relacorilant plus nab-paclitaxel shows positive results in ovarian cancer
- ErVimmune raises 17m euros in funding to develop cancer vaccine
- Book your tickets and join the PM Society for the 40th PM Awards on 20 March 2026
- Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma
